Pershing Square USA, Ltd. (“PSUS” or the “Company”), issued the following statement:

To clarify press reports, Pershing Square USA. Ltd. is proceeding with its initial public offering (the “IPO”) of its common shares of beneficial interest (the “Common Shares”) with the date of pricing to be announced.

The IPO price will be $50.00 per Common Share. PSUS has applied to list the Common Shares on the New York Stock Exchange under the symbol “PSUS.” PSUS intends to invest the net proceeds of the IPO in accordance with its investment objective and policies.

Our press release correcting false and misleading press reports on the Pershing Square USA $PSUS IPO:

https://t.co/88gnutFF13

— Bill Ackman (@BillAckman) July 27, 2024

A registration statement on Form N-2 relating to the Common Shares has been filed with the U.S. Securities and Exchange Commission (the “SEC”) but has not yet become effective. The Common Shares may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. The IPO will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the IPO may be obtained by visiting EDGAR on the SEC’s website at www.sec.gov.

Alternatively, copies of the preliminary prospectus may be obtained by contacting the offices of Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146); UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by telephone at (888) 827-7275, or by email at ol-prospectus-request@ubs.com; BofA Securities, NC1-022-02-25, Attention: Prospectus Department, 201 North Tryon Street, Charlotte, North Carolina 28255, or by email at: dg.prospectus_requests@bofa.com; Jefferies LLC at Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388, or by e-mail at Prospectus_Department@Jefferies.com.

Source: Pershing Square